deltatrials
Completed PHASE1 NCT00003410

Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas

Pilot Trial of Gadolium Texaphyrin for Magnetic Resonance Imaging-Guided Resection of High Grade Gliomas

Sponsor: Jonsson Comprehensive Cancer Center

Conditions Brain and Central Nervous System Tumors
Interventions magnetic resonance imaging motexafin gadolinium surgical procedure
Updated 5 times since 2017 Last updated: Jun 25, 2013 Started: Jul 31, 1998 Completion: Jun 30, 2004

Listed as NCT00003410, this PHASE1 trial focuses on Brain and Central Nervous System Tumors and remains completed. Sponsored by Jonsson Comprehensive Cancer Center, it has been updated 5 times since 1998, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Jul 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Jonsson Comprehensive Cancer Center
  • National Cancer Institute (NCI)
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Los Angeles, United States